$0.4680
-0.0247-5.01%
At close: Jun 8, 5:00 PM EST
$0.4925
0.02455.24%
After Hours: 6:12 PM EST
Jasper Therapeutics Inc Earnings Estimates
JSPRNASDAQ
Jasper Therapeutics Earnings Estimates, EPS & Revenue | NASDAQ:JSPR
Jasper Therapeutics (JSPR) is scheduled to report Q2 earnings on August 12, 2026. Analysts estimate EPS of $-0.52 and quarterly revenue of N/A.
In the most recent quarter (Q1), Jasper Therapeutics reported EPS of $-0.04, beating estimates of $-0.52 by 0.92%. Revenue came in at $0.00, meeting the estimate of $0.00 by 0.00%.
Jasper Therapeutics has beaten EPS estimates in 3 consecutive quarters.
Over the last 4 quarters, Jasper Therapeutics has averaged an EPS surprise of 0.48% and a revenue surprise of 0.00%.
Earnings Date
Aug 12
EPS Estimate
$-0.520
Quarterly Revenue Estimate
–
Annual Revenue
(as of Mar 31)
(as of Mar 31)
–
Jasper Therapeutics Earnings History
Analyze the earnings history of Jasper Therapeutics using advanced sorting and filters.
Loading calendar...
Jasper Therapeutics (JSPR) Earnings Per Share
The chart below shows Jasper Therapeutics's reported EPS compared to analyst estimates over recent quarters.
Jasper Therapeutics (JSPR) Revenue
The chart below shows Jasper Therapeutics's reported revenue compared to analyst estimates over recent quarters.
FAQ
When is Jasper Therapeutics (NASDAQ:JSPR) reporting earnings?
Jasper Therapeutics (JSPR) is scheduled to report earnings on August 12, 2026. The last reported earnings were for reported on May 14, 2026 for Q1.
What were the latest earnings per share (EPS) for Jasper Therapeutics (NASDAQ:JSPR)?
The Actual EPS was $-0.04, which beat the estimate of $-0.52.
What were Jasper Therapeutics’s (NASDAQ:JSPR) revenues?
The Actual Revenue was $0.00, which hit the estimate of $0.00.
